US Patent Issued to GC Cell, Incyte on Dec. 9 for "Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and natural killer cell" (South Korean, German Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,244, issued on Dec. 9, was assigned to GC Cell Corp. (Seoul, South Korea) and Incyte Corp. (Wilmington, Del.).

"Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and natural killer cell" was invented by Jung Hyun Her (Gyeonggi-do, South Korea), Mi Young Jung (Gyeonggi-do, South Korea), Su Hyun Gwon (Gyeonggi-do, South Korea), Ho Yong Lim (Gyeonggi-do, South Korea), Sung Yoo Cho (Gyeonggi-do, South Korea), Sung Yong Won (Gyeonggi-do, South Korea), Yu Kyeong Hwang (Gyeonggi-do, South Korea), Jan Endell (Planegg, Germany) and Rainer Boxhammer (Planegg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a pharma...